Behrouz Hassannia

4.8k total citations · 2 hit papers
16 papers, 2.7k citations indexed

About

Behrouz Hassannia is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Behrouz Hassannia has authored 16 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Behrouz Hassannia's work include Ferroptosis and cancer prognosis (10 papers), RNA modifications and cancer (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Behrouz Hassannia is often cited by papers focused on Ferroptosis and cancer prognosis (10 papers), RNA modifications and cancer (5 papers) and Cancer, Lipids, and Metabolism (5 papers). Behrouz Hassannia collaborates with scholars based in Belgium, United States and Cuba. Behrouz Hassannia's co-authors include Tom Vanden Berghe, Peter Vandenabeele, Koen Augustyns, Bartosz Wiernicki, Yulia Y. Tyurina, Hülya Bayır, Samya Van Coillie, Andy Wullaert, Valerian E. Kagan and Wim Vanden Berghe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Cell and Nature Protocols.

In The Last Decade

Behrouz Hassannia

15 papers receiving 2.7k citations

Hit Papers

Targeting Ferroptosis to Iron Out Cancer 2019 2026 2021 2023 2019 2023 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting Ferroptosis to Iron Out Cancer
    2019 1.9k citations Behrouz Hassannia, Peter Vandenabeele et al. Cancer Cell profile →
  2. Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors
    2023 116 citations Greta Klejborowska, Behrouz Hassannia et al. Trends in Pharmacological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behrouz Hassannia Belgium 12 1.8k 1.8k 1.3k 289 265 16 2.7k
Daiha Shin South Korea 19 1.3k 0.7× 1.4k 0.8× 1.1k 0.8× 326 1.1× 157 0.6× 31 2.3k
Fereshteh Zandkarimi United States 19 3.0k 1.6× 2.7k 1.5× 2.4k 1.8× 425 1.5× 158 0.6× 29 4.2k
Jennifer Yinuo Cao United States 9 1.5k 0.8× 1.6k 0.9× 1.2k 0.9× 355 1.2× 78 0.3× 9 2.6k
Deguang Liang United States 5 1.1k 0.6× 1.0k 0.6× 865 0.6× 176 0.6× 85 0.3× 6 1.7k
Leslie Magtanong United States 15 3.6k 2.0× 3.5k 2.0× 2.8k 2.1× 502 1.7× 156 0.6× 15 5.2k
Bufu Tang China 23 699 0.4× 1.1k 0.6× 727 0.5× 321 1.1× 135 0.5× 85 1.8k
Shumei Ma China 27 756 0.4× 1.2k 0.7× 839 0.6× 290 1.0× 90 0.3× 50 2.0k
Qiaoyou Weng China 26 619 0.3× 1.3k 0.7× 640 0.5× 293 1.0× 179 0.7× 77 2.2k
Ruonan Zhang China 17 504 0.3× 757 0.4× 459 0.3× 253 0.9× 104 0.4× 59 1.4k
Elizabeth S. Henson Canada 18 677 0.4× 1.5k 0.9× 798 0.6× 465 1.6× 89 0.3× 34 2.3k

Countries citing papers authored by Behrouz Hassannia

Since Specialization
Citations

This map shows the geographic impact of Behrouz Hassannia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behrouz Hassannia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behrouz Hassannia more than expected).

Fields of papers citing papers by Behrouz Hassannia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behrouz Hassannia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behrouz Hassannia. The network helps show where Behrouz Hassannia may publish in the future.

Co-authorship network of co-authors of Behrouz Hassannia

This figure shows the co-authorship network connecting the top 25 collaborators of Behrouz Hassannia. A scholar is included among the top collaborators of Behrouz Hassannia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behrouz Hassannia. Behrouz Hassannia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Klejborowska, Greta, Ashley M. Toye, Emily Van San, et al.. (2025). Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases. Journal of Medicinal Chemistry. 68(4). 4908–4928. 2 indexed citations
2.
Hassannia, Behrouz, et al.. (2025). Harnessing ferroptosis for precision oncology: challenges and prospects. BMC Biology. 23(1). 57–57. 8 indexed citations
3.
Aalders, J.G., et al.. (2024). Improving cardiac differentiation of human pluripotent stem cells by targeting ferroptosis. Regenerative Therapy. 27. 21–31.
4.
San, Emily Van, Yulia Y. Tyurina, Vladimir A. Tyurin, et al.. (2023). Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell Death and Differentiation. 30(9). 2092–2103. 52 indexed citations
5.
Klejborowska, Greta, et al.. (2023). Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors. Trends in Pharmacological Sciences. 44(12). 902–916. 116 indexed citations breakdown →
6.
Hassannia, Behrouz, Bartosz Wiernicki, Bruno Verstraeten, et al.. (2023). Molecular Mechanisms of Nemorosone-Induced Ferroptosis in Cancer Cells. Cells. 12(5). 735–735. 13 indexed citations
7.
Ghazavi, Farzaneh, Stephanie Schulz, Sofie Martens, et al.. (2022). Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state. Proceedings of the National Academy of Sciences. 119(6). 14 indexed citations
8.
Hassannia, Behrouz, Bartosz Wiernicki, A. Díaz, et al.. (2022). Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines. Molecules. 27(13). 3970–3970. 54 indexed citations
9.
Hassannia, Behrouz, Samya Van Coillie, & Tom Vanden Berghe. (2020). Ferroptosis: Biological Rust of Lipid Membranes. Antioxidants and Redox Signaling. 35(6). 487–509. 65 indexed citations
10.
Wiernicki, Bartosz, Yulia Y. Tyurina, Behrouz Hassannia, et al.. (2020). Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis. Cell Death and Disease. 11(10). 922–922. 188 indexed citations
11.
Hassannia, Behrouz, Emilie Logie, Peter Vandenabeele, Tom Vanden Berghe, & Wim Vanden Berghe. (2019). Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug. Biochemical Pharmacology. 173. 113602–113602. 93 indexed citations
12.
Hassannia, Behrouz, Peter Vandenabeele, & Tom Vanden Berghe. (2019). Targeting Ferroptosis to Iron Out Cancer. Cancer Cell. 35(6). 830–849. 1860 indexed citations breakdown →
13.
Herck, Simon Van, Behrouz Hassannia, Benoit Louage, et al.. (2018). Water-soluble withaferin A polymer prodrugs via a drug-functionalized RAFT CTA approach. European Polymer Journal. 110. 313–318. 10 indexed citations
14.
Berghe, Tom Vanden, Behrouz Hassannia, & Peter Vandenabeele. (2016). An outline of necrosome triggers. Cellular and Molecular Life Sciences. 73(11-12). 2137–2152. 105 indexed citations
15.
Grootjans, Sasker, Behrouz Hassannia, Iris Delrue, et al.. (2016). A real-time fluorometric method for the simultaneous detection of cell death type and rate. Nature Protocols. 11(8). 1444–1454. 50 indexed citations
16.
Hofmans, Sam, Tom Vanden Berghe, Behrouz Hassannia, et al.. (2015). Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties. Journal of Medicinal Chemistry. 59(5). 2041–2053. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daiha Shin Breakdown of academic impact, for papers by Fereshteh Zandkarimi Breakdown of academic impact, for papers by Jennifer Yinuo Cao Breakdown of academic impact, for papers by Deguang Liang Breakdown of academic impact, for papers by Leslie Magtanong Breakdown of academic impact, for papers by Bufu Tang Breakdown of academic impact, for papers by Shumei Ma Breakdown of academic impact, for papers by Qiaoyou Weng Breakdown of academic impact, for papers by Ruonan Zhang Breakdown of academic impact, for papers by Elizabeth S. Henson
Rankless by CCL
2026